SOURCE: Wall Street Equity Research

Wall Street Equity Research

August 18, 2010 08:57 ET

Professional Research on Walgreen and CVS Caremark -- Competition Set at Maximum Level

JOHANNESBURG, SOUTH AFRICA--(Marketwire - August 18, 2010) -  www.wallstreetequityresearch.com gives shareholders valuable insight on drug stores stocks Walgreen Co. (NYSE: WAG) and CVS Caremark Corporation (NYSE: CVS). Sign up today at www.wallstreetequityresearch.com to receive free research reports on these equities.

With the economy still struggling, drug stores are trying to find new ways to drum up business. With flu season just around the corner, many major drug stores like Walgreen Co. and CVS Caremark Corp. have doubled or tripled the number of qualified pharmacists in their stores that can administer flu vaccinations. Traders can get direct and free access to today's full reports on Walgreen Co. and CVS Caremark Corporation by signing up at http://wallstreetequityresearch.com/August182010WalgreenCo.(WAG)180810.php or http://wallstreetequityresearch.com/August182010CVSCaremarkCorporation(CVS)180810.php.

www.wallstreetequityresearch.com is a specialized website where investors can have specific access to free reports drug stores industry; traders looking for analyst opinions on Walgreen Co., CVS Caremark Corporation and other companies in this industry are welcomed to sign up for a free one year membership at http://www.wallstreetequityresearch.com/.

The industry is also looking to different advertizing mediums such as social networking sites. As prescription drug use has fallen due to the economic slowdown, retailers have added alcohol and other products to their shelves in an attempt to get people through the door. Visit us at http://www.wallstreetequityresearch.com/ to understand the catalysts and forces driving or affecting the drug stores industry in today's economic environment.

Generic drug alternatives have also been impacting drug store bottom lines, as the cheaper alternatives are driving down profits. This trend many lessen in the coming months, as insurers are dropping their previous subsidies issued to consumers who purchase generic alternatives. While this bodes well for drug stores, it has had a brutal effect on companies involved in the disbursement of generic drugs.

About Wall Street Equity Research: 

Wall Street Equity Research looks to bring simplicity and highly sophisticated research to an ever-changing investing environment. Wall Street Equity Research has been partnering with a number of North American and Emerging Economies analysts to bring you the best of both continents in terms of market analysis and analytical opinions. 

Contact Information